Summary:
In this podcast, patient advocate and KRAS Kickers founder, Terri Conneran, talks about how much knowing what biomarker was driving her cancer would've mattered for her treatment, and how that turned into a community around the KRAS mutation. She also gives her advice for pharma on how clinical trials can be discussed with patients and how patients might view clinical trials as a care option.
For more information on patient engagement in clinical research, visit PatientsAsPartnersConference.com. For more information about clinical research as a care option, visit CRAACOEvent.com.
Speaker
Related Podcasts
View All
Understanding Financial Barriers to Getting More Coverage for Patients in Clinical Trials
How Montefiore Gets Early Stage Clinical Trials to Under-Resourced Communities
Working with Patient Organizations to Use Patient Insights Meaningfully throughout Medicine & Disease Lifecycles
